Quarterly Focus on Genitourinary Cancer: Highlights in Prostate Cancer

April 12, 2018

  • Share this post:

Publications in peer-reviewed journals are a major source for keeping up with the latest developments in your field. However, you may not always have sufficient time to study (difficult) publications thoroughly and to determine the impact on your clinical practice. To support you, MEDtalks Oncology has developed a new program format: the Quarterly Focus. This innovative program brings an expert panel and authors of relevant, selected publications together to explain and discuss the new data.

Two pivotal, international publications from the past few months will be clarified by one of the authors and will be thoroughly discussed by an expert panel including the author. The program will give you the possibility to gain more insight into the selected publications.
During the live broadcast on Thursday April 26th 8.30-9.30 PM CEST you have the unique opportunity to interact with our expert panel and the authors and ask them your questions.

The expert panel consist of:

  • André Bergman MD, PhD, medical oncologist, Netherlands Cancer Institute, Amsterdam
  • Martijn Lolkema MD, PhD, medical oncologist, Erasmus MC, Rotterdam
  • Niven Mehra MD, PhD, medical oncologist, Radboudumc, Nijmegen

Provisional program:

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
J Clin Oncol 36, 2018

Speaker: Prof. Gert De Meerleer MD, PhD, radiation oncologist, UZ Leuven, Belgium

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
J Clin Oncol 35, 2017

Speaker: Jun Luo MD, PhD, cell and molecular biologist, Brady Urological Institute, US

This program is editorially independent and is financially supported by: